Philip Gutry Appointed as Kronos Bio’s Chief Business Officer to Expand Pipeline Opportunities 글 내용 전체보기
Vedanta Biosciences Initiate Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for Inflammatory Bowel Disease 글 내용 전체보기
Vedanta Biosciences Initiate Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for Inflammatory Bowel Disease 글 내용 전체보기
Novo Nordisk’s Oral semaglutide demonstrates favourable cardiovascular safety profile and significant reduction in cardiovascular death and all-cause mortality in people with type 2 diabetes in the PIONEER 6 trial 글 내용 전체보기
Positive Data from Phase 3 ECHELON-2 Clinical Trial Presented by Seattle Genetics and Takeda for ADCETRIS® (Brentuximab Vedotin) in Frontline Treatment of CD30-Expressing Peripheral T-Cell Lymphomas 글 내용 전체보기
Novartis drug Revolade® Real-world data shows improved outcomes for ITP patients compared to other second-line therapies 글 내용 전체보기
Initial Clinical Data from Ongoing Phase 1/2 Evolve Trial with Anti-BCMA CAR T Therapy JCARH125 in Relapsed/Refractory Multiple Myeloma at ASH 2018 Announced by Celgene Corporation 글 내용 전체보기
Two-Year Data for Yescarta® (Axicabtagene Ciloleucel) in Patients With Refractory Large B-Cell Lymphoma Announced by Kite 글 내용 전체보기
